Advances in the use of fecal DNA screening for the detection of colorectal cancer

Clinical Colorectal Cancer

Volumn 2, Issue 4, 2003, Pages 210-212

  DeGrendele, Heather ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DNA; PROTEIN P53;

COLORECTAL CANCER; DNA DETERMINATION; DNA EXTRACTION; DNA ISOLATION; DNA PURIFICATION; DNA SCREENING; FECES ANALYSIS; GENE AMPLIFICATION; GENE MUTATION; HUMAN; MARKER GENE; NON INVASIVE MEASUREMENT; ONCOGENE K RAS; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

EID: 0037303307     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1533-0028(11)70329-2     Document Type: Review

References (16)

1. Jenal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26.
2. Pignone M, Levin B. Recent developments in colorectal cancer screening and prevention. Am Fam Physician 2002; 66:297-302.
3. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343:1603-1607.
4. Verne JE, Aubrey R, Love SB, et al. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 1998; 317:182-185.
5. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256:102-105.
6. Nollau P, Moser C, Weinland G, et al. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 1996; 66:332-336.
7. Villa E, Dugani A, Rebecchi AM, et al. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterology 1996; 110:1346-1353.
8. Boland CR, Sato J, Saito K, et al. Genetic instability and chromosomal aberrations in colorectal cancer: a review of the current models. Cancer Detect Prev 1998; 22:377-382.
9. Jen J, Powell SM, Papadopoulos N, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994; 54:5523-5526.
10. Schwartz RS. A needle in a haystack of genes. N Engl J Med 2002; 346:302-304.
11. Tsao J, Shibata D. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC. Am J Pathol 1994; 145:531-534.
12. Laurent-Puig P, Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1998; 26:269-270.
13. Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002; 346:311-320.
14. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000; 119:1219-1227.
15. Brand RE, Shuber AP, Laken SJ, et al. Reliability of a stool DNA mutation specific assay for colorectal cancer. Gastroenterology 2002; 122:A-479 (Abstract #T1554).
16. Tagore K, Ross M, Shuber AP, et al. Stool DNA multi-target assay for the detection of colorectal cancer and advanced adenomas. Gastroenterology 2002; 122:A-481 (Abstract #T1563).